News about Global Pharma

BioDlink Launches Bevacizumab Biosimilar in Colombia and Pakistan

BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria.<br />

Global Pharma | 14/08/2025 | By Dineshwori |  252

Avendus Invests INR 300 Cr in Aragen Life Sciences

Avendus Future Leaders Fund (FLF), the flagship private strategies fund of the Avendus Group, has led an INR 300 crore investment in Aragen Life Sciences from its third fund, along with SBI Life Insurance.

Global Pharma | 14/08/2025 | By Dineshwori |  228

Sartorius Stedim Biotech Partners with Nanotein Technologies to Advance Cell Therapy Manufacturing

Sartorius Stedim Biotech partners with Nanotein Technologies, investing up to USD 3 million to commercialise and distribute NanoSpark immune cell activation solutions for cell therapy applications.

Global Pharma | 14/08/2025 | By Mrinmoy Dey |  136

Apriori Bio Partners with Francis Crick Institute to Advance Variant-Resilient Vaccine Research

Apriori Bio has partnered with the Francis Crick Institute to leverage AI-driven insights and the Crick’s Legacy Study for developing variant-resilient vaccines against current and emerging viral threats.

Global Pharma | 14/08/2025 | By Mrinmoy Dey |  216

Xspray Pharma Licenses Dasatinib Patents to Handa Therapeutics for US and Asian Markets

Xspray Pharma has entered into a license agreement with Handa Therapeutics, granting Handa a non-exclusive license to certain Xspray patents.

Global Pharma | 14/08/2025 | By Dineshwori |  271

PharmaTher Receives FDA Approval for KETARx Ketamine in Surgical Pain Management

PharmaTher Holdings Ltd. has received approval from the US Food and Drug Administration (FDA) for its ketamine product, KETARx, for use in surgical pain management.

Global Pharma | 14/08/2025 | By Dineshwori |  287

Centrient Pharmaceuticals Joins UN Global Compact, Strengthens Sustainability Commitment

Centrient Pharmaceuticals has officially joined the United Nations Global Compact (UNGC), reinforcing its commitment to ethical and sustainable growth.

Global Pharma | 13/08/2025 | By Dineshwori |  314

Cohance Lifesciences Invests INR 23 Cr on New cGMP Oligonucleotide Facility at Hyderabad

Cohance Lifesciences has announced an investment of INR 230 million and significant progress on its new cGMP oligonucleotide building block manufacturing facility in Hyderabad, India.

Global Pharma | 13/08/2025 | By Dineshwori |  385

Fosun Pharma and Expedition Therapeutics Enter Global Licensing Agreement for Innovative Respiratory Drug XH-S004

Fosun Pharma Industrial has signed a global License Agreement with Expedition Therapeutics Inc., granting the US-based biotechnology company the rights to develop, manufacture, and commercialise its investigational respiratory drug XH-S004 in all regions worldwide, excluding the Chinese Mainland, Hong Kong SAR, and Macau SAR.

Global Pharma | 13/08/2025 | By Dineshwori |  282

Sandoz Partners with Elawan Energy to Decarbonize European Operations

Sandoz has signed a 10-year virtual Power Purchase Agreement (PPA) with Elawan Energy to co-develop 150 MW of new solar projects in Valladolid, Castilla y Leon, Spain.

Global Pharma | 12/08/2025 | By Dineshwori |  227